Developing a package testing plan that avoids product launch delays
The medical device industry is a fast-changing environment that is continuously adapting to the constant challenges within the medical landscape. One such challenge is designing safe, sterile packaging that will protect products during shipping and transport while complying with FDA or international health and safety regulations. Many medical device companies struggle with the development of test plans to determine which procedure to specify for package performance testing. And the recent revision to the ASTM D4169 and ISO 11607 standards, as well as FDA’s acceptance of International Safe Transit Associations Series 3 standards, add additional layers of complexity.
Eurofins’ Dr. Sunny J. Modi will be presenting solutions to these challenges at MD&M East, June 13 at 10:30 am, UBM’s Tech Theater. This presentation will provide an overview of different testing standards, the current status and expectations of the FDA, as well as a discussion on the new guidance, current impact and what may be coming.
Dr. Modi is Director of Package Testing for Eurofins Medical Device Testing with 10 years of experience, focusing on creating and testing packaging materials. He specializes in transport simulation, accelerated aging, and mechanical testing with a thorough understanding of ASTM, ISTA, and ISO protocols for package integrity testing. Dr. Modi participates in the technical review committee for the International Safe Transit Association and is an active member of Institute of Packaging Professionals and the Association for the Advancement of Medical Instrumentation. Dr. Modi earned his Ph.D. and M.S. degrees from the Ohio State University focusing in packaging and composite applications.